Status:
COMPLETED
Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111)
Lead Sponsor:
Organon and Co
Conditions:
Androgenetic Alopecia
Eligibility:
MALE
40-60 years
Phase:
PHASE3
Brief Summary
A clinical study to collect additional data in order to characterize the reduction in PSA with finasteride 1 mg, and its reversibility in men with androgenetic alopecia between the ages of 40 to 60 ye...
Eligibility Criteria
Inclusion
- Inclusion Criteria :
- Men 40 to 60 years of age, and in good general physical and mental health, with androgenetic alopecia
- Exclusion Criteria :
- History of previous bladder surgery, acute urinary retention, urethral strictures, repeated urethral catheterizations, repeated urinary tract infections, or active urinary tract infections
- History of treatment with finasteride (PROSCAR or PROPECIA) or hypersensitivity to any component of finasteride.
Exclusion
Key Trial Info
Start Date :
March 1 1998
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
355 Patients enrolled
Trial Details
Trial ID
NCT00396175
Start Date
March 1 1998
Last Update
February 17 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.